Biotech events - Theoria Creative

RESI JPM 2024(Redefining Early-stage Investments)
2024-01-09 - 2024-01-10
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.

Fierce JPM Week 2024
2024-01-09 - 2024-01-10
Connecting Minds, Igniting Change, Navigating the Future of Biopharma and Healthcare
A pivotal election, new regulations, and an array of technological advancements are poised to usher in a year marked by innovation and change for biopharma and healthcare.
From thought-provoking discussions on the ever-evolving deal dynamics within the industry to unique insights on the regulatory landscape, treatment breakthroughs, and the strategic deployment of AI, some of the greatest minds in pharma and healthcare will convene to explore the most pressing issues and exciting opportunities on the horizon.

BIO Partnering at JPM Week
2024-01-08 - 2024-01-12
BIO One-on-One Partnering unifies access to partnering for the life science industry. You can efficiently arrange meetings with biotechs, investors, in-licensors, medical device and medtech companies, and other life science leaders, regardless of whether you are registered for a specific event during JPM Week.

The CSSi LifeSciences Partnering Forum during the Annual J.P. Morgan Healthcare Conference
2024-01-08 - 2024-01-11
The event provides a unique opportunity for participating sponsors to meet emerging and established life science companies that require a broad range of professional services to advance their products to commercial success. In 2023, we had 1000+ in-person participants from 600+ companies. The Forum drew companies and organizations from 23 countries including Australia, Canada, Hong Kong, Ireland, Israel, France, Germany, Italy, Japan, Korea, Singapore, Switzerland and the United Kingdom.

JPM 2024 42nd Annual Healthcare Meeting
2024-01-08 - 2024-01-11
Join 42nd JPM Healthcare Conference 2025 in San Francisco, CA, USA.
This premier conference is the largest and most informative healthcare investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.
Health Community features the leading innovators and latest innovations from around the world which are addressing today’s health and wellness challenges. Learn how the latest advances, leading research and best practices are being applied to grow and scale digital health solutions.

Biotech Showcase - San Francisco
2024-01-08 - 2024-01-10
This rapidly growing conference features multiple tracks of curated presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings using the industry’s gold-standard platform, partneringONE®.
In addition to biopharmaceutical and life science company executives, Biotech Showcase delegates include investors in private and public companies, sector analysts, bankers and industry professionals.
Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a combined history of over 50 years in producing high quality programs that support the growth of the biotechnology and broader life sciences industry.
